FCH
USNA icon

Freestone Capital Holdings’s Usana Health Sciences USNA Stock Holding History

Freestone Capital Holdings’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,298
Closed -$536K – 365
2017
Q1 		$536K Sell
9,298
-163
-2% -$9.73K 0.04% 266
2016
Q4 		$579K Buy
+9,461
New +$616K 0.05% 248

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Freestone Capital Holdings's USNA Position: Q2 2017 in Review

Freestone Capital Holdings sold out of Usana Health Sciences (USNA) in Q2 2017, closing a stake of 9,298 shares — an estimated $536K sold.

Freestone Capital Holdings first reported a position in USNA in Q4 2016 and held it in 2 quarters. The position peaked at $579K in Q4 2016. 145 funds tracked by Wall St. Rank hold USNA as of Q2 2017.

  • Freestone Capital Holdings reported no remaining Usana Health Sciences position as of Q2 2017 after selling out during the quarter.
  • Freestone Capital Holdings sold 9,298 Usana Health Sciences shares in Q2 2017, an estimated $536K.
  • Freestone Capital Holdings first reported a position in Usana Health Sciences in Q4 2016 and held it in 2 quarters.
  • Freestone Capital Holdings's Usana Health Sciences position peaked at $579K in Q4 2016.
  • 145 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2017.

Based on Freestone Capital Holdings's 13F filing for Q2 2017, filed 10 Aug 2017.